BCM
Bayesian Capital Management’s Viking Therapeutics VKTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Buy |
+16,200
| New | +$429K | 0.07% | 317 |
|
|
2024
Q4 | – | Sell |
-4,200
| Closed | -$266K | – | 1018 |
|
|
2024
Q3 | $266K | Buy |
+4,200
| New | +$266K | 0.03% | 503 |
|
|
2023
Q3 | – | Sell |
-16,664
| Closed | -$270K | – | 1024 |
|
|
2023
Q2 | $270K | Buy |
+16,664
| New | +$270K | 0.03% | 567 |
|
|
2021
Q2 | – | Sell |
-12,800
| Closed | -$81K | – | 659 |
|
|
2021
Q1 | $81K | Buy |
+12,800
| New | +$81K | 0.02% | 499 |
|
|
2018
Q4 | – | Sell |
-11,600
| Closed | -$202K | – | 801 |
|
|
2018
Q3 | $202K | Buy |
+11,600
| New | +$202K | 0.03% | 566 |
|